Intracervical release of ST-1435 for contraception

Kurunmäki, H.; Toivonen, J.; Lähteenmäki, P.L.; Luukkainen, T.

Contraception 29(5): 411-421

1984


ISSN/ISBN: 0010-7824
PMID: 6430641
DOI: 10.1016/0010-7824(84)90015-5
Document Number: 562807
Seven women used an ST-1435-releasing intracervical contraceptive device (ST-ICD), inserted immediately after the cessation of menstrual bleeding. Patterns of bleeding and clinical performance were evaluated and plasma concentrations of ST-1435, estradiol, progesterone and gonadotropins were measured by radioimmunoassays. The results of ten months of treatment are presented. There were no uniform patterns of bleeding. No hormonal side-effects were registered. The plasma concentration of ST-1435 reached 100 pg/ml within two hours after insertion of an ST-ICD. No ovulations occurred during the initial three months of treatment. A rapid decline in the plasma concentrations of ST-1435 was observed; during the tenth month the concentration of ST-1435 was under the sensitivity of the radioimmunoassay of ST-1435. Hence, the release of ST-1435 from Silastic was too rapid for long-acting contraceptive purposes.

Document emailed within 0-6 h
Secure & encrypted payments